This website uses cookies to provide necessary functionality and to improve your online experience. By using this website you accept our use of cookies and the Privacy Statement.
Name of study | APIs and strength | Base | Action |
---|---|---|---|
In Vitro Evaluation of the Percutaneous Absorption of Diclofenac Sodium in Medisca VersaPro Gel Base | Diclofenac Sodium | VersaPro Gel Base | |
Development and Validation of HPLC Assay Method for Stability Testing of a High-Potency Diclofenac Sodium Gel | Diclofenac Sodium | VersaPro Gel Base | |
Stability Assessment of Compounded Bracketed Diclofenac Sodium 1-15% in Medisca VersaPro Gel Base | Diclofenac Sodium | VersaPro Gel Base | |
Stability Assessment of Compounded Bracketed Testosterone 0.02-25% in Medisca VersaPro Gel Base | Testosterone | VersaPro Gel Base | |
In Vitro Evaluation of the Percutaneous Absorption of Ketoprofen, Diclofenac Sodium and Lidocaine Hydrochloride in Medisca VersaPro™ Cream Base and Medisca VersaPro Gel Base | Ketoprofen, Ketoprofen, Diclofenac Sodium, Diclofenac Sodium, Lidocaine Hydrochloride, Lidocaine Hydrochloride | VersaPro Cream Base, VersaPro Gel Base, VersaPro Cream Base, VersaPro Gel Base, VersaPro Cream Base, VersaPro Gel Base | |
Stability Assessment of Compounded Bracketed Estradiol 0.01-0.2%, Estriol 0.04-0.8%, Progesterone 1-20%, Testosterone 0.025-0.5% and DHEA 0.2-4% in Medisca VersaPro Cream Base | Estradiol, Estriol, Progesterone, Testosterone, DHEA | VersaPro Cream Base, VersaPro Cream Base, VersaPro Cream Base, VersaPro Cream Base, VersaPro Cream Base | |
Stability Assessment of Compounded Benzocaine 20%, Lidocaine 6% and Tetracaine 4% in Medisca VersaPro Cream Base | Benzocaine, Lidocaine, Tetracaine | VersaPro Cream Base, VersaPro Cream Base, VersaPro Cream Base | |
Stability Assessment of Compounded Cyclobenzaprine Hydrochloride 5%, Diclofenac Sodium 10% and Lidocaine 5% in Medisca VersaPro Cream Base | Cyclobenzaprine Hydrochloride, Diclofenac Sodium, Lidocaine | VersaPro Cream Base, VersaPro Cream Base, VersaPro Cream Base | |
Stability Assesment of Compounded Bracketed Estradiol 0.025-0.25%, Estriol 0.025-0.25% and Testosterone 1-10% in Medisca VersaPro Cream Base | Estradiol, Estriol, Testoterone | VersaPro Cream Base, VersaPro Cream Base, VersaPro Cream Base | |
Stability Assesment of Compounded Bracketed Estradiol 0.025-0.5%, Estriol 0.025-0.5% and Progesterone 1-20% in Medisca VersaPro Cream Base | Estradiol, Estriol, Progesterone | VersaPro Cream Base, VersaPro Cream Base, VersaPro Cream Base | |
Ninety Day Chemical Stability of Compounded Estradiol, Estrone and Estriol Combination and Beyond Use Date (potency-over-time only) | Estradiol, Estriol, Estrone | VersaPro Cream Base, VersaPro Cream Base, VersaPro Cream Base | |
Stability Assesment of Compounded Bracketed Estradiol 0.025-0.5% and Estriol 0.1-2% in Medisca VersaPro Cream Base | Estradiol, Estriol | VersaPro Cream Base, VersaPro Cream Base | |
Stability Assessment of Compounded Bracketed Estriol 0.01-10% in Medisca VersaPro Cream Base | Estriol | VersaPro Cream Base | |
Stability Assessment of Compounded Bracketed Ketamine 0.5-8.5% in Medisca VersaPro Cream Base | Ketamine Hydrochloride | VersaPro Cream Base | |
Stability Assessment of Compounded Bracketed Ketoprofen 2.5-30% in Medisca VersaPro Cream Base | Ketoprofen | VersaPro Cream Base | |
Stability Assessment of Compounded Bracketed Progesterone 1-40% in Medisca VersaPro Cream Base | Progesterone | VersaPro Cream Base | |
Stability Assessment of Compounded Bracketed Diclofenac Sodium 1-15% in Medisca VersaPro Cream Base | Diclofenac Sodium | VersaPro Cream Base | |
Stability Assessment of Compounded Bracketed Testosterone 0.02-25% in Medisca VersaPro Cream Base | Testosterone | VersaPro Cream Base | |
Chemical Stability of Hydrocortisone in Topical Preparation in Proprietary VersaPro Cream Base (potency-over-time only) | Hydrocortisone | VersaPro Cream Base | |
In Vitro Evaluation of the Percutaneous Absorption of Progesterone in Medisca VersaPro Cream Base | Progesterone | VersaPro Cream Base |
Rows per page